IDT and SGI-DNA Broaden Their Collaboration to Provide Synthetic DNA Products up to 2 Mbp
February 28, 2013
CORALVILLE, IA AND LA JOLLA, CA -- Integrated DNA Technologies, Inc. (IDT) and SGI-DNA announce an expanded partnership to develop, manufacture, and market a variety of synthetic DNA products. IDT is the world’s leader in custom oligonucleotide synthesis and SGI-DNA is a newly formed subsidiary of Synthetic Genomics, Inc. (SGI), which focuses on genomic-driven solutions [...]
Dividend Proposal by the Board of Directors
February 28, 2013
Aubagne | Goettingen, – At yesterday’s meeting, the Board of Directors of Sartorius Stedim Biotech S.A. resolved to submit a proposal to the Annual General Shareholders' Meeting (AGM) on April 16, 2013, to pay a dividend of €1.10 per share for fiscal 2012. Compared with a year earlier, dividends per share would increase by 10.0% [...]
Lake Shore to Launch THz Materials Characterization System at APS March Meeting, Booth 800
February 28, 2013
Lake Shore Cryotronics will announce its new continuous wave terahertz materials characterization system at the American Physical Society March Meeting 2013. The conference, which will take place March 18 to 22 in Baltimore, is the largest physics meeting in the world, focusing on research from industry, universities, and national labs. The Lake Shore product, slated [...]
MOCON Adds Expert to GreenLight® Food Safety Business, Expands European Marketing Efforts
February 28, 2013
MOCON, Inc. (NASDAQ: MOCO) is increasing European marketing efforts for its GreenLight® food safety line with the addition of an industry leader to its team. Henk van der Meer has joined MOCON as a microbial detection consultant. Van der Meer has held several senior food safety diagnostic positions throughout his career, including 23 years as [...]
Fast Acting Arthritogenic Monoclonal Antibody Cocktails
February 28, 2013
Collagen Antibody-Induced Arthritis (CAIA) has been widely used since 1998 when 4-clone cocktail (Arthrogen-CIA® arthritogenic monoclonal antibodies) kits first appeared. In order to induce consistent arthritis more effectively in various mouse strains including CAIA low responder C57BL/6 mice, and a variety of unpredictable knockout and transgenic mice with C57BL/6 (H-2b) or 129/Sv (H-2b) backgrounds, a [...]
ChemAxon provides chemistry informatics platform for the European Lead Factory
February 28, 2013
ChemAxon, a leader in providing chemistry software solutions and consulting services for life science research, and the European Lead Factory, a novel platform for innovative drug discovery, announces that ChemAxon will provide the core tools and leads the development of the informatics platform to support the pan European initiative. ChemAxon will be building a portal [...]
February 28, 2013
Today Roche and Hamilton Robotics jointly announced the introduction of a new, integrated platform enabling automated DNA sample enrichment for Roche’s 454 GS Junior sequencer. The platform builds on the integration of Roche’s REM e System with Hamilton’s Microlab® NIMBUS NGS workstation, resulting in reduced hands-on time, minimized operational variability and more consistent results. “This [...]
SPECTRO Presents XRF Package of Methods for Cement Industry
February 28, 2013
Kleve, — SPECTRO plans to present an elemental screening package for the cement industry at the seventh Global CemFuels Conference, March 11 to 14, 2013 in Istanbul. X-ray fluorescence analysis (XRF) has become especially useful for determining harmful substances in secondary fuels and has become a favorite technology, because of its ability to rapidly conduct [...]
Tecan Group AG : Tecan appoints Dr. Stefan Traeger to the Management Board
February 28, 2013
Männedorf, Switzerland, - The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has appointed Dr. Stefan Traeger as a member of the Management Board. As Head of the Life Sciences Business division Stefan Traeger will be responsible for the Group's global end-customer business. He will take up his new post at Tecan on [...]
BioGenes Reports Strong Growth of HCP Assay Development Business
February 28, 2013
Berlin, Germany, - BioGenes GmbH, a global leader in host cell protein (HCP) assay development, announced a strong increase in sales volume in 2012, the year of the company’s 20th anniversary, due to a high demand of specific antibodies and ELISA assays used in drug development processes. In particular, the HCP assay development business showed [...]
